Dermatology · Cromwell, CT
NPI
1952575573
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Willowbrook Rd Ste 2
Cromwell, CT, 06416
Phone (860) 322-2222
Groups this clinician bills Medicare through
Medicare paid, 2024
$248K
4,714 services
Medicare patients, 2024
452
Average age 77
Drug cost, 2024
$2.4M
1,465 prescriptions
Company payments, 2025
$851K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Payette was code 17003 (destruction skin lesion), 895 times for 143 patients. In total Michael J Payette billed 4,714 services in 60 codes, and Medicare paid $248K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 895 | 143 | $5.23 | $4,680 |
| 99213 Office E&M - Established | Office | 397 | 304 | $63.71 | $25K |
| 17000 Destruction Skin Lesion | Office | 262 | 213 | $36.74 | $9,625 |
| 99214 Office E&M - Established | Office | 232 | 155 | $94.46 | $22K |
| 11102 Skin Biopsy | Office | 171 | 147 | $66.86 | $11K |
| 17110 Destruction Skin Lesion | Office | 156 | 119 | $87.95 | $14K |
| 96372 Injection Administration | Office | 72 | 26 | $10.28 | $740 |
| 11103 Skin Biopsy | Office | 65 | 37 | $40.78 | $2,650 |
| 17004 Destruction Skin Lesion | Office | 37 | 29 | $127.14 | $4,704 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 18 | $13.42 | $362 |
| 12032 Wound Repair - All Levels | Office | 26 | 23 | $234.03 | $6,085 |
| 11603 Skin Lesion Excision | Office | 18 | 14 | $117.21 | $2,110 |
| 69100 Other Organ Systems | Office | 13 | 13 | $52.66 | $685 |
| 99203 Office E&M - New | Office | 11 | 11 | $92.84 | $1,021 |
| 99204 Office E&M - New | Office | 11 | 11 | $113.70 | $1,251 |
By year: 2022 $258K for 4,192 services; 2023 $278K for 4,192 services; 2024 $248K for 4,714 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Payette prescribed most often to Medicare patients was Dupixent Syringe (Dupilumab), with 146 prescriptions and refills. In total Michael J Payette wrote 1,465 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Syringe Dupilumab | 146 | 146 | 14 | $614K |
| Triamcinolone Acetonide Generic | 121 | 137 | 86 | $1,568 |
| Dupixent Pen Dupilumab | 96 | 117 | 14 | $455K |
| Mupirocin Generic | 69 | 69 | 44 | $539 |
| Ketoconazole Generic | 67 | 81 | 24 | $889 |
| Doxycycline Hyclate Generic | 63 | 117 | 41 | $2,176 |
| Hydrocortisone Generic | 52 | 52 | 35 | $280 |
| Valacyclovir Valacyclovir Hcl | 50 | 97 | 15 | $2,064 |
| Minoxidil Generic | 46 | 138 | 19 | $825 |
| Clobetasol Propionate Generic | 43 | 44 | 33 | $994 |
| Betamethasone Dipropionate Generic | 42 | 43 | 27 | $1,504 |
| Doxycycline Monohydrate Generic | 40 | 96 | 18 | $2,845 |
| Terbinafine Hcl Generic | 29 | 49 | 15 | $331 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 29 | 33 | 19 | $673 |
| Tretinoin Generic | 29 | 31 | Under 11 | $1,061 |
Brand drugs: 459 claims; generic drugs: 1,006 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Payette $851K ($851K in general payments such as food, travel and fees) from 25 companies. The largest payer was UCB, Inc. with $138K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 182 | $138K |
| Abbvie Inc. ABBV | 162 | $138K |
| Regeneron Healthcare Solutions, Inc. REGN | 60 | $93K |
| Incyte Corporation INCY | 74 | $79K |
| Lilly USA, LLC LLY | 84 | $64K |
| Janssen Biotech, Inc. JNJ | 60 | $51K |
| Pfizer Inc. PFE | 43 | $50K |
| Galderma Laboratories, L.P. GALD.SW | 52 | $47K |
| Genzyme Corporation SNY | 28 | $46K |
| Arcutis Biotherapeutics, Inc. ARQT | 39 | $41K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.